Goodman Group (ASX: GMG) shares have been relatively positive performers this year.

Since the start of the year, the industrial property giant’s shares have risen approximately 4%.

This compares favourably to a largely flat performance from the S&P/ASX 200 Index (ASX: XJO).

But what’s to come for this popular stock? Could it deliver double-digit returns over the next 12 months? Let’s see what analysts are saying.

Could Goodman shares deliver big returns?

The broker community is overwhelmingly positive on Goodman, with many brokers having the equivalent of buy ratings on its shares.

One of those brokers is Bell Potter, which has a buy rating and $35.50 price target on them.

Based on the current Goodman share price of $32.17, this implies potential upside of 10% for investors over the next 12 months. It recently commented:

While we do have some question marks visà-vis leasing progress, extension of timelines and associated impact on earnings mix and booking of profits, the moat around the haves and have nots for scaled data centre players appears to be widening, recognising the scale and complexity of execution. Post pull back, GMG trades at a discount to its 5yr PE vs. ASX200 avg (28% prem. vs. 52% 5yr avg) with forward customer signings a key driver.

Who else is bullish?

The team at Morgan Stanley is another bull. Earlier this week, the broker put an overweight rating and $36.15 price target on its shares. This suggests that upside of 12% is possible between now and this time next year.

Another broker that is positive is Morgans. It has a buy rating and $36.00 price target, which offers similar upside. It commented:

GMG’s 3Q26 update reinforced a deliberate strategy: deploy balance-sheet capital ahead of customer commitments to win the race for power-enabled metro data centre (DC) capacity. WIP is set to step from $14.5bn at Mar-26 to a record c.$18bn by Jun-26 (Consensus $17.7bn), with the power bank lifted to 6.4GW.

Operationally the update was mixed, with pre-committed share, production rate and Yield On Cost (YOC) all relatively flat hoh. The structurally important note was management’s view that industry DC capex requirements likely exceed global capital market funding capacity, a backdrop that favours those with secured power, sites and locked-in capital partners. FY26 OEPSg guided to ‘at least 9%’ (prior 9%; MorgansF 9.2%; Consensus 9.8%), marginally up.

Finally, the team at Citi has a buy rating and $40.00 price target on Goodman shares. This implies potential upside of approximately 24% for investors over the next 12 months.

The post Could Goodman shares rise more than 20%? appeared first on The Motley Fool Australia.

More reading

• Where to invest your Westpac dividends
• 8 ASX 200 shares with reaffirmed buy recommendations this week
• These ASX shares are riding the AI boom. Investors keep overlooking them
• The ASX investing strategy that could quietly make you rich
• New to investing? 3 ASX shares to set and forget until 2036

Motley Fool contributor James Mickleboro has positions in Goodman Group. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has positions in and has recommended Goodman Group. The Motley Fool Australia has recommended Goodman Group. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

It has been another painful day for shareholders of Judo Capital Holdings Ltd (ASX: JDO) shares.

The ASX bank stock extended its heavy sell-off on Friday morning, falling another 2% to $0.90 after already shedding around 40% over recent trading sessions.

That leaves Judo Capital shares down roughly 49% in 2026 and 42% over the past 12 months. By comparison, the S&P/ASX 200 Index (ASX: XJO) has gained approximately 2.2% over the same period.

So, what’s behind the dramatic collapse?

Investors didn’t like Judo’s latest update

The sell-off began after Judo released revised expectations for FY 2026 on Thursday that left investors questioning the bank’s near-term outlook.

While management still expects earnings to grow this financial year, it also revealed that bad debt costs are rising faster than previously anticipated.

The biggest concern was the bank’s updated cost of risk guidance. Judo now expects its FY 2026 cost of risk to come in between $116 million and $122 million, reflecting an increase in specific loan provisions.

Management of Judo Capital shares said the higher provisioning relates primarily to three individual customer exposures across different industries that have deteriorated following customer-specific developments.

Although the issues appear concentrated rather than widespread, investors rarely welcome surprises when it comes to credit quality.

The bank also expects loans that are either more than 90 days overdue or classified as impaired to rise to around 3% of gross loans and advances by 30 June. That’s another sign that some borrowers are finding conditions increasingly challenging.

There were a few positives

The update wasn’t entirely negative. Judo said its collective provision coverage should remain broadly unchanged from its third-quarter trading update, equating to 94 basis points of gross loans and advances.

Management also noted that current provisioning includes additional overlays designed to protect against ongoing macroeconomic uncertainty across vulnerable sectors.

In other words, Judo Capital believes it has built a reasonable buffer against further deterioration.

Profit growth is still expected, just not as much

Perhaps the biggest disappointment for investors in Judo Capital shares was a downgrade to earnings guidance. Judo now expects FY 2026 profit before tax of between $163 million and $169 million.

While that would still represent approximately 30% growth on FY 2025, it falls well short of the bank’s previous guidance of $180 million to $190 million.

Looking further ahead, management of the $2 billion ASX share expects FY 2027 profit before tax of between $210 million and $220 million, implying another year of roughly 30% earnings growth despite ongoing macroeconomic and geopolitical uncertainty.

Chief Executive officer Chris Bayliss acknowledged the disappointment but maintained confidence in the business. He said the latest update was partly driven by the broader economic backdrop but stressed that Judo Capital remains profitable, well capitalised, and has a clear pathway to delivering a return on equity in the low-to-mid teens.

What’s next for Judo Capital shares?

For now, investors appear focused on rising credit losses rather than future profit growth.

The market has become far less forgiving of banks reporting deteriorating loan quality, particularly when expectations were already high.

That said, Judo’s long-term growth story hasn’t disappeared overnight. The lender continues to grow its business banking franchise, remains profitable, and is forecasting another two years of double-digit earnings growth.

The post What on earth’s going on with Judo Capital shares? appeared first on The Motley Fool Australia.

More reading

• 8 ASX 200 shares with reaffirmed buy recommendations this week
• Why Judo Capital, Minerals 260, Santos, and Worley shares are dropping today
• Which ASX 200 bank stock is crashing 46% on profit guidance downgrade?
• RBA keeps cash rate at 4.35% – What does it mean for investors?
• Broker names 3 ASX shares to buy now

Motley Fool contributor Marc Van Dinther has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

Ramsay Health Care Ltd (ASX: RHC) shares are edging lower today.

Shares in the S&P/ASX 200 Index (ASX: XJO) healthcare stock closed yesterday trading for $42.74. In late morning trade on Friday, shares are changing hands for $42.65 apiece, down 0.2%.

For some context, the ASX 200 is just about flat at this same time.

Taking a step back, Ramsay Health Care shares have strongly outperformed in 2026, up 23.3% compared to the 0.3% year to date gains posted by the benchmark index.

And the ASX 200 healthcare stock also recently increased its passive income payouts, boosting its fully franked interim dividend by 6.3% to 42.5 cents a share.

Ramsay Health Care stock currently trades on a 1.9% fully franked trailing dividend yield.

And looking ahead, Nathan Hughes, an Australian equities portfolio manager at Perpetual, believes there’s plenty more upside potential for the Aussie-focused healthcare provider (courtesy of The Australian Financial Review).

Here’s why.

Should I buy Ramsay Health Care shares today?

Asked which stock his fund holds that’s most undervalued by the market, Hughes replied, “Ramsay Health Care presents compelling upside.”

He noted, “The negatives, such as labour inflation and changes to private health insurance rebates that may impact industry participation, are now well understood.”

And Ramsay Health Care shares could benefit from their renewed focus on the Aussie market.

According to Hughes:

Beyond the demerger of the Ramsay Santé assets – the European hospitals business Ramsay announced it would spin off in February – we think it’s clear the focus of the company is the core Australian business.

There is significant opportunity to improve operating performance and asset productivity in this division, with a sensible approach to capacity and utilisation in contrast to years of expansion. As such, return on invested capital should improve.

Hughes also pointed to the company’s strong balance sheet and the fully franked dividend on offer as reasons to be optimistic for ongoing share price growth.

He concluded:

Further capital repatriation from offshore is not out of the question in the medium term. This would give the company plenty of financial flexibility, noting Ramsay has a large balance of surplus franking credits.

What’s the latest from the ASX 200 healthcare stock?

Ramsay reported its half year results (H1 FY 2026) on 26 February.

Highlights for the six months to 31 December included underlying earnings before interest and tax (EBIT) of $536.7, up 7.3% year on year.

And on the bottom line, underlying net profit after tax (NPAT) of $171.7 million increased by 8.1%.

Ramsay Health Care shares closed up 10.4% on the day of the results release.

The post Up 23% this year, why Ramsay Health Care shares are tipped for more ‘compelling upside’ appeared first on The Motley Fool Australia.

More reading

• Ramsay Health Care shares rebound 15% in June: Can they keep going?
• Healthcare shares led the ASX 200 last week. Is a sector comeback underway?

Motley Fool contributor Bernd Struben has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.